Study of testosterone level and prostate cancer prognosis

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200060022

Enrollment

Unknown

Registered

2022-05-15

Start date

2022-05-05

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

case series:None

Eligibility

Sex/Gender

Male

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. Diagnosed with prostate cancer after pathological confirmation.

Exclusion criteria

Exclusion criteria: At the same time with other tumours.

Design outcomes

Primary

Measure	Time frame
Overall Survival;CRPC-free Survival;	—

Countries

China

Contacts

Public ContactChen Rui

Shanghai Changhai Hospital

drchenrui@foxmail.com+86 13764301103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026